A role for leptin in immune-mediated inflammatory diseases?

por Gabay, C, Palmer, G
Publicado 2004

Novel intracellular function of IL-1 receptor antagonist type 1 in endothelial cells

por Gabay, C, Soussi, F, Berti, M
Publicado 2003

Mice deficient in leptin (ob/ob) or in liptin receptor (db/db) have a milder form of antigen-induced arthritis

por Busso, N, So, V, Péclat, A, Gabay, C
Publicado 2001

Secreted IL-1Ra exerts a protective effect on atherosclerotic lesion development in apolipoprotein-E-deficient mice

por Soussi, F, Kwak, BR, Pelli, G, Mach, F, Gabay, C
Publicado 2003

NLRP3 Q703K and TNFRSF1A R92Q mutations in a patient with auto inflammatory disease

por von Mühlenen, I, Gabay, C, Finckh, A, Kuemmerle-Deschner, J
Publicado 2015

Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice

por Bernotiene, E, Palmer, G, Talabot-Ayer, D, Szalay-Quinodoz, I, Gabay, C
Publicado 2003

Intracellular IL-1 receptor antagonist (icIL-1Ra1) does not antagonize growth inhibitory effects of pre-IL-1α in SaOS-2 cells

por Palmer, G, Trolliet, S, Talabot-Ayer, D, Mézin, F, Magne, D, Gabay, C
Publicado 2005

Statins have no effect on collagen-induced arthritis in mice

por Palmer, G, Chobaz, V, Talabot, D, Taylor, S, So, A, Gabay, C, Busso, N
Publicado 2004

Effects of leflunomide on interleukin-1 receptor antagonist (IL-1Ra) synthesis in chondrocytes and synovial fibroblasts

por Palmer, G, Burger, D, Mezin, F, Gabay, C, Dayer, J-M, Guerne, P-A
Publicado 2003

Production of interleukin (IL)-1 receptor antagonist by human articular chondrocytes

por Palmer, G, Guerne, PA, Mezin, F, Maret, M, Guicheux, J, Goldring, MB, Gabay, C
Publicado 2002

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid...

por Finckh, A, Tellenbach, C, Herzog, L, Scherer, A, Moeller, B, Ciurea, A, von Muehlenen, I, Gabay, C, Kyburz, D, Brulhart, L, Müller, R, Hasler, P, Zufferey, P
Publicado 2020

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an a...

por Finckh, A, Ciurea, A, Brulhart, L, Möller, B, Walker, U A, Courvoisier, D, Kyburz, D, Dudler, J, Gabay, C, Arthritis, on the behalf of the doctors of the Swiss Clinical Quality Management Programme for Rheumatoid
Publicado 2010

OR6-004 – MRP8/14 promote MSU-crystal induced inflammation

por Holzinger, D, Nippe, N, Vogl, T, Marketon, K, Mysore, V, Weinhage, T, Dalbeth, N, Pool, B, Merriman, T, Baeten, D, Ives, A, Bagnoud, N, Busso, N, Foell, D, Bas, S, Gabay, C, Roth, J
Publicado 2013